Exporters line up for restricted API licence

The government, on March 3, restricted the exports of 26 API and formulations, including paracetamol and vitamins B1, B6 and B12 in order to ensure there is no shortage of drugs in India due to the lockdown in China’s Hubei’s province, the epicentre of the coronavirus outbreak, and a major source of these raw materials.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2WfhOMr
via IFTTT